You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 97 No. 2, FEBRUARY 1956 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Comparative Study of the Treatment of Essential Hypertension

The Effect of Rauwolfia and a Rauwolfia Compound (Rauwolfia, Mannitol Hexanitrate, and Rutin)

SYDNEY STONEHILL, M.D.

AMA Arch Intern Med. 1956;97(2):189-193.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Although Rauwolfia has been used in India for centuries because of its sedative effect in such conditions as insanity, hysteria, insomnia, etc., it was not until 1933 that its hypotensive effect was reported.1 In 1931 Siddiqui and Siddiqui2 were able to isolate five crystalline alkaloids from the whole alkaloid Reserpine. These compounds have been used in combination with other hypotensive drugs such as hexamethonium, pentolinium (pentapyrrolidinium), hydralazine, and Veratrum alkaloids.* This study concerns itself with the hypotensive effect of the powdered whole root from Rauwolfia micrantha alone and when combined with rutin and mannitol hexanitrate (Maxitate).

MATERIALS AND METHODS

A total of 17 patients with moderate to severe hypertension were observed for a period of one year. The blind test technique was used. All tablets were of identical appearance, and were labeled 7-71, 7-72, and 7-73. The composition of the tablets is as follows:

7-71 Rauwolfia micrantha.... 30 . . . [Full Text PDF of this Article]


Footnotes

Submitted for publication Aug. 17, 1955.

Department of Internal Medicine, Rochester General Hospital.

This study was made possible through a grantin-aid from R. J. Strasenburgh Co., Rochester, N. Y.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1956 American Medical Association. All Rights Reserved.